Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.

Xiong MY, Rizzo AE, Cohen TS, Dyer RK, Korgavkar K, Bingham SF, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention(VATTC) Trial Group.

J Invest Dermatol. 2013 Jun;133(6):1521-32. doi: 10.1038/jid.2013.35. Epub 2013 Feb 24.

2.

Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.

Dyer RK, Weinstock MA, Cohen TS, Rizzo AE, Bingham SF; VATTC Trial Group.

J Invest Dermatol. 2012 Nov;132(11):2544-51. doi: 10.1038/jid.2012.227. Epub 2012 Jul 19.

3.

Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.

Weinstock MA, Bingham SF, Digiovanna JJ, Rizzo AE, Marcolivio K, Hall R, Eilers D, Naylor M, Kirsner R, Kalivas J, Cole G, Vertrees JE; Veterans Affairs Topical Tretinoin Chemoprevention Trial Group.

J Invest Dermatol. 2012 Jun;132(6):1583-90. doi: 10.1038/jid.2011.483. Epub 2012 Feb 9.

4.

Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.

Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial.

J Natl Cancer Inst. 2008 Sep 3;100(17):1223-32. doi: 10.1093/jnci/djn262. Epub 2008 Aug 26.

5.
6.

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group.

Cancer. 2009 Jun 1;115(11):2523-30. doi: 10.1002/cncr.24284.

7.

Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use.

van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2546-8. Epub 2006 Nov 28.

8.

Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.

Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):157-61.

9.

Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.

Weinstock MA, Lee KC, Chren MM, Marcolivio K; VATTC Trial Group.

J Am Acad Dermatol. 2009 Aug;61(2):207-15. doi: 10.1016/j.jaad.2009.02.022. Epub 2009 Apr 26.

10.

A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study.

Grodstein F, Speizer FE, Hunter DJ.

J Natl Cancer Inst. 1995 Jul 19;87(14):1061-6.

PMID:
7616597
11.

Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Geng A, Weinstock MA, Hall R, Eilers D, Naylor M, Kalivas J; VATTC Trial Group.

Br J Dermatol. 2009 Oct;161(4):918-24. doi: 10.1111/j.1365-2133.2009.09341.x. Epub 2009 Jun 11.

PMID:
19681859
12.

Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.

Baibergenova AT, Weinstock MA; VATTC Trial Group.

J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1109-15. doi: 10.1111/j.1468-3083.2011.04226.x. Epub 2011 Sep 16.

PMID:
21923839
13.

Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.

Maurer TA, Christian KV, Kerschmann RL, Berzin B, Palefsky JM, Payne D, Tyring SK, Berger TG.

Arch Dermatol. 1997 May;133(5):577-83.

PMID:
9158410
14.

Topical tretinoin therapy and all-cause mortality.

Weinstock MA, Bingham SF, Lew RA, Hall R, Eilers D, Kirsner R, Naylor M, Kalivas J, Cole G, Marcolivio K, Collins J, Digiovanna JJ, Vertrees JE; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group.

Arch Dermatol. 2009 Jan;145(1):18-24. doi: 10.1001/archdermatol.2008.542.

PMID:
19153339
15.

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB.

J Natl Cancer Inst. 2010 Dec 15;102(24):1835-44. doi: 10.1093/jnci/djq442. Epub 2010 Nov 29.

16.

The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin.

Zanetti R, Rosso S, Martinez C, Navarro C, Schraub S, Sancho-Garnier H, Franceschi S, Gafà L, Perea E, Tormo MJ, Laurent R, Schrameck C, Cristofolini M, Tumino R, Wechsler J.

Br J Cancer. 1996 Jun;73(11):1440-6.

17.

Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Lee KC, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group.

J Am Acad Dermatol. 2010 Dec;63(6):1107-9. doi: 10.1016/j.jaad.2010.02.014. No abstract available.

PMID:
21093671
18.

Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.

Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, Lang C, Russell A.

Lancet. 1999 Aug 28;354(9180):723-9. Erratum in: Lancet 1999 Sep 18;354(9183):1038.

PMID:
10475183
19.

A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.

Chen AC, Martin AJ, Choy B, Fernández-Peñas P, Dalziell RA, McKenzie CA, Scolyer RA, Dhillon HM, Vardy JL, Kricker A, St George G, Chinniah N, Halliday GM, Damian DL.

N Engl J Med. 2015 Oct 22;373(17):1618-26. doi: 10.1056/NEJMoa1506197.

20.

Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings.

Gordon LG, Scuffham PA, van der Pols JC, McBride P, Williams GM, Green AC.

J Invest Dermatol. 2009 Dec;129(12):2766-71. doi: 10.1038/jid.2009.141. Epub 2009 Jun 18.

Items per page

Supplemental Content

Write to the Help Desk